Editorial: diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases
Aliment Pharmacol Ther
.
2015 Jul;42(1):119-20.
doi: 10.1111/apt.13235.
Authors
K M Taylor
1
,
M P Sparrow
2
Affiliations
1
Inflammatory Bowel Disease Unit, Department of Gastroenterology, The Alfred Hospital, Melbourne, Vic., Australia.
2
Inflammatory Bowel Disease Unit, Department of Gastroenterology, The Alfred Hospital, Melbourne, Vic., Australia. m.sparrow@alfred.org.au.
PMID:
26040520
DOI:
10.1111/apt.13235
No abstract available
Publication types
Editorial
Comment
MeSH terms
Diabetes Mellitus / epidemiology*
Female
Humans
Immunologic Factors / therapeutic use*
Inflammatory Bowel Diseases / drug therapy*
Male
Substances
Immunologic Factors